Selecta Biosciences Inc. (SELB) NASDAQ
$0.88 (0.08) (-8.00%)
Market Cap: $136.77M
As of 11/13/23 04:00 PM EST. Market closed.
Selecta Biosciences Inc. (SELB)
NASDAQ
$0.88
(0.08) (-8.00%)
Market Cap: $136.77M
As of 11/13/23 04:00 PM EST. Market closed.
selecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options. the company’s current proprietary pipeline ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SPRINGER TIMOTHY A | Director | Mar 08, 2024 | Buy | $0.66 | 4,800 | 3,187 | 95,218 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 18, 2024 | Buy | $0.61 | 800 | 488 | 104,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Feb 07, 2024 | Buy | $0.66 | 2,400 | 1,575 | 90,418 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 15, 2024 | Buy | $0.56 | 1,200 | 672 | 104,018 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Feb 06, 2024 | Buy | $0.65 | 800 | 520 | 88,018 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 14, 2024 | Buy | $0.53 | 2,000 | 1,061 | 102,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Jan 17, 2024 | Buy | $0.69 | 800 | 552 | 87,218 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 13, 2024 | Buy | $0.58 | 3,200 | 1,868 | 100,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 12, 2024 | Buy | $0.61 | 1,200 | 735 | 97,618 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 11, 2024 | Buy | $0.65 | 1,200 | 785 | 96,418 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 26, 2024 | Option Exercise | $1.46 | 1,970,443 | 2,876,847 | 33,043,849 | Mar 26, 2024, 04:32 PM |
SPRINGER TIMOTHY A | Director | Mar 18, 2024 | Buy | $0.60 | 19,044 | 11,398 | 31,073,406 | Mar 20, 2024, 05:09 PM |
SPRINGER TIMOTHY A | Director | Mar 15, 2024 | Buy | $0.59 | 537,500 | 314,545 | 31,054,362 | Mar 18, 2024, 05:29 PM |
SPRINGER TIMOTHY A | Director | Mar 14, 2024 | Buy | $0.54 | 648,372 | 351,677 | 30,516,862 | Mar 18, 2024, 05:29 PM |
Brunn Carsten | President and CEO | Nov 13, 2023 | Option Exercise | $2.06 | 521,125 | 1,073,517 | 728,081 | Nov 15, 2023, 05:26 PM |
SPRINGER TIMOTHY A | Director | Nov 15, 2023 | Option Exercise | $403.47 | 123,925 | 49,999,835 | 123,925 | Nov 15, 2023, 05:20 PM |
SPRINGER TIMOTHY A | Director | Nov 15, 2023 | Option Exercise | $403.47 | 24,785 | 9,999,967 | 24,785 | Nov 15, 2023, 05:20 PM |
Brunn Carsten | President and CEO | Sep 25, 2023 | Sale | $1.06 | 2,932 | 3,108 | 783,081 | Sep 26, 2023, 06:01 PM |
TRABER PETER G | Chief Medical Officer | Sep 25, 2023 | Sale | $1.06 | 705 | 747 | 451,826 | Sep 26, 2023, 06:00 PM |
Brunn Carsten | President and CEO | Jan 05, 2023 | Sale | $1.13 | 13,473 | 15,214 | 786,090 | Jan 06, 2023, 05:16 PM |
Brunn Carsten | President and CEO | Jan 04, 2023 | Sale | $1.13 | 27,597 | 31,287 | 799,534 | Jan 06, 2023, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 05, 2023 | Sale | $1.13 | 3,392 | 3,830 | 265,535 | Jan 06, 2023, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 04, 2023 | Sale | $1.13 | 6,392 | 7,247 | 268,918 | Jan 06, 2023, 05:16 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 05, 2023 | Sale | $1.13 | 3,392 | 3,830 | 364,336 | Jan 06, 2023, 05:15 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 04, 2023 | Sale | $1.13 | 6,392 | 7,247 | 367,719 | Jan 06, 2023, 05:15 PM |
TRABER PETER G | Chief Medical Officer | Jan 05, 2023 | Sale | $1.13 | 3,465 | 3,913 | 446,141 | Jan 06, 2023, 05:15 PM |
TRABER PETER G | Chief Medical Officer | Jan 04, 2023 | Sale | $1.13 | 8,179 | 9,273 | 449,601 | Jan 06, 2023, 05:15 PM |
Brunn Carsten | President and CEO | Dec 05, 2022 | Sale | $1.33 | 4,522 | 6,014 | 544,283 | Dec 07, 2022, 04:17 PM |
Brunn Carsten | President and CEO | Sep 28, 2022 | Sale | $1.66 | 2,692 | 4,470 | 537,867 | Sep 30, 2022, 07:37 PM |
Brunn Carsten | President and CEO | Sep 02, 2022 | Sale | $1.85 | 4,768 | 8,810 | 540,559 | Sep 06, 2022, 08:37 PM |
COX CARRIE SMITH | Director | Jun 13, 2022 | Buy | $1.15 | 130,000 | 149,799 | 212,881 | Jun 15, 2022, 04:16 PM |
BARABE TIMOTHY C | Director | May 09, 2022 | Buy | $0.77 | 50,000 | 38,720 | 250,013 | May 11, 2022, 04:21 PM |
BARABE TIMOTHY C | Director | Jan 14, 2022 | Option Exercise | $2.10 | 10,000 | 21,000 | 200,013 | Jan 18, 2022, 04:19 PM |
TRABER PETER G | Chief Medical Officer | Jan 05, 2022 | Sale | $3.09 | 3,226 | 9,955 | 251,355 | Jan 07, 2022, 04:18 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 05, 2022 | Sale | $3.09 | 3,416 | 10,541 | 268,353 | Jan 07, 2022, 04:18 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 05, 2022 | Sale | $3.09 | 3,416 | 10,541 | 175,299 | Jan 07, 2022, 04:18 PM |
Brunn Carsten | President and CEO | Jan 05, 2022 | Sale | $3.09 | 13,597 | 41,959 | 517,958 | Jan 07, 2022, 04:17 PM |
SPRINGER TIMOTHY A | Director | Dec 15, 2021 | Buy | $2.99 | 211,190 | 631,099 | 23,186,890 | Dec 17, 2021, 04:36 PM |
TRABER PETER G | Chief Medical Officer | Dec 10, 2021 | Sale | $2.99 | 4,083 | 12,196 | 164,381 | Dec 14, 2021, 05:17 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 10, 2021 | Sale | $2.99 | 4,370 | 13,053 | 199,769 | Dec 14, 2021, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Dec 10, 2021 | Sale | $2.99 | 4,370 | 13,053 | 106,715 | Dec 14, 2021, 05:16 PM |
Brunn Carsten | President and CEO | Dec 10, 2021 | Sale | $2.99 | 17,196 | 51,363 | 305,255 | Dec 14, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 13, 2021 | Buy | $2.98 | 14,592 | 43,491 | 22,975,700 | Dec 13, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 10, 2021 | Buy | $2.99 | 58,681 | 175,439 | 22,961,108 | Dec 13, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 09, 2021 | Buy | $3.06 | 3,748,000 | 11,468,880 | 22,902,427 | Dec 13, 2021, 05:16 PM |
Tan Kevin | Chief Financial Officer | Dec 02, 2021 | Buy | $3.03 | 5,000 | 15,127 | 5,000 | Dec 06, 2021, 04:25 PM |
DeSilva Nishan M | Director | Dec 02, 2021 | Buy | $2.96 | 7,000 | 20,723 | 7,000 | Dec 06, 2021, 04:25 PM |
COX CARRIE SMITH | Director | Dec 03, 2021 | Buy | $2.95 | 17,200 | 50,664 | 82,881 | Dec 06, 2021, 04:25 PM |
Brunn Carsten | President and CEO | Dec 02, 2021 | Sale | $2.96 | 4,746 | 14,065 | 284,951 | Dec 03, 2021, 04:28 PM |
TRABER PETER G | Chief Medical Officer | Oct 13, 2021 | Sale | $4.39 | 3,636 | 15,962 | 154,714 | Oct 15, 2021, 06:08 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Oct 13, 2021 | Sale | $4.39 | 3,892 | 17,086 | 190,389 | Oct 15, 2021, 06:07 PM |
Johnston Lloyd P. | Chief Operations Officer | Oct 13, 2021 | Sale | $4.39 | 3,892 | 17,086 | 97,335 | Oct 15, 2021, 06:07 PM |
Brunn Carsten | President and CEO | Oct 13, 2021 | Sale | $4.39 | 15,313 | 67,224 | 278,759 | Oct 15, 2021, 06:07 PM |
Brunn Carsten | President and CEO | Sep 02, 2021 | Sale | $4.51 | 4,523 | 20,399 | 229,372 | Sep 03, 2021, 04:18 PM |
BARABE TIMOTHY C | Director | Aug 18, 2021 | Buy | $4.00 | 9,000 | 36,000 | 190,013 | Aug 20, 2021, 06:09 PM |
BARABE TIMOTHY C | Director | Mar 26, 2021 | Buy | $4.10 | 10,000 | 41,000 | 181,013 | Mar 30, 2021, 04:50 PM |
TRABER PETER G | Chief Medical Officer | Mar 18, 2021 | Buy | $4.50 | 10,000 | 45,000 | 98,000 | Mar 19, 2021, 05:34 PM |
TRABER PETER G | Chief Medical Officer | Mar 17, 2021 | Buy | $4.53 | 10,000 | 45,295 | 88,000 | Mar 19, 2021, 05:34 PM |
Johnston Lloyd P. | COO and SVP, R&D | Mar 17, 2021 | Sale | $4.45 | 15,128 | 67,312 | 87,477 | Mar 19, 2021, 05:33 PM |
Brunn Carsten | President and CEO | Mar 02, 2021 | Sale | $4.26 | 5,461 | 23,257 | 216,826 | Mar 03, 2021, 05:21 PM |
Johnston Lloyd P. | COO and SVP, R&D | Feb 11, 2021 | Option Exercise | $0.63 | 44,871 | 28,269 | 102,605 | Feb 16, 2021, 06:10 PM |
TRABER PETER G | Chief Medical Officer | Dec 14, 2020 | Buy | $3.24 | 40,000 | 129,424 | 40,000 | Dec 16, 2020, 04:31 PM |
Brunn Carsten | President and CEO | Dec 02, 2020 | Sale | $3.35 | 3,323 | 11,134 | 101,350 | Dec 03, 2020, 04:22 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Oct 23, 2020 | Option Exercise | $2.77 | 30,000 | 83,100 | 126,149 | Oct 27, 2020, 05:13 PM |
SPRINGER TIMOTHY A | Director | Oct 23, 2020 | Buy | $2.71 | 994,488 | 2,699,737 | 14,480,948 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 22, 2020 | Buy | $2.63 | 1,770,204 | 4,656,699 | 13,486,460 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 21, 2020 | Buy | $2.50 | 880,000 | 2,199,472 | 11,716,256 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 20, 2020 | Buy | $2.21 | 910,000 | 2,013,193 | 10,836,256 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 19, 2020 | Buy | $2.36 | 759,500 | 1,795,002 | 9,926,256 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 16, 2020 | Buy | $2.42 | 218,196 | 528,034 | 9,166,756 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 09, 2020 | Buy | $2.00 | 276,703 | 552,465 | 8,948,560 | Oct 14, 2020, 04:18 PM |
SPRINGER TIMOTHY A | Director | Oct 08, 2020 | Buy | $1.89 | 530,441 | 1,000,836 | 8,671,857 | Oct 08, 2020, 05:50 PM |
SPRINGER TIMOTHY A | Director | Oct 07, 2020 | Buy | $1.65 | 654,953 | 1,078,577 | 8,141,416 | Oct 08, 2020, 05:50 PM |
SPRINGER TIMOTHY A | Director | Oct 06, 2020 | Buy | $1.68 | 2,000,000 | 3,365,800 | 7,486,463 | Oct 08, 2020, 05:50 PM |
BARABE TIMOTHY C | Director | Oct 06, 2020 | Buy | $1.68 | 50,000 | 83,985 | 171,013 | Oct 08, 2020, 04:25 PM |
Brunn Carsten | President and CEO | Sep 02, 2020 | Sale | $2.39 | 3,364 | 8,035 | 93,735 | Sep 03, 2020, 04:29 PM |
BARABE TIMOTHY C | Director | Jun 24, 2020 | Option Exercise | $1.46 | 32,840 | 47,946 | 121,013 | Jun 26, 2020, 04:21 PM |
Brunn Carsten | President and CEO | Jun 02, 2020 | Sale | $3.86 | 3,253 | 12,557 | 86,162 | Jun 03, 2020, 04:42 PM |
BARABE TIMOTHY C | Director | Mar 17, 2020 | Buy | $2.00 | 5,000 | 10,000 | 88,173 | Mar 19, 2020, 05:16 PM |
Brunn Carsten | President and CEO | Mar 03, 2020 | Sale | $3.86 | 3,374 | 13,011 | 78,477 | Mar 03, 2020, 04:25 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jan 16, 2020 | Option Exercise | $0.47 | 5,128 | 2,410 | 16,734 | Jan 21, 2020, 05:21 PM |
BARABE TIMOTHY C | Director | Dec 23, 2019 | Option Exercise | $1.46 | 65,681 | 95,894 | 83,173 | Dec 26, 2019, 05:30 PM |
SPRINGER TIMOTHY A | Director | Dec 23, 2019 | Option Exercise | $1.46 | 3,940,887 | 5,753,695 | 5,486,463 | Dec 26, 2019, 05:30 PM |
COX CARRIE SMITH | Director | Dec 23, 2019 | Option Exercise | $1.46 | 65,681 | 95,894 | 65,681 | Dec 26, 2019, 05:30 PM |
Myers Scott Dunseth | Director | Dec 23, 2019 | Option Exercise | $1.46 | 39,409 | 57,537 | 80,845 | Dec 26, 2019, 05:29 PM |
Brunn Carsten | President and CEO | Dec 02, 2019 | Sale | $1.53 | 14,272 | 21,809 | 70,914 | Dec 03, 2019, 04:20 PM |
SPRINGER TIMOTHY A | Director | Aug 20, 2019 | Option Exercise | $1.81 | 1,100,000 | 1,991,000 | 1,545,576 | Aug 20, 2019, 04:33 PM |
SPRINGER TIMOTHY A | Director | Aug 20, 2019 | Option Exercise | $1.81 | 1,600,000 | 2,896,000 | 6,056,597 | Aug 20, 2019, 04:33 PM |
Smolinski Stephen | Chief Commercial Officer | Aug 20, 2019 | Option Exercise | $1.81 | 13,812 | 25,000 | 13,812 | Aug 20, 2019, 04:32 PM |
Myers Scott Dunseth | Director | Aug 20, 2019 | Option Exercise | $1.81 | 41,436 | 74,999 | 41,436 | Aug 20, 2019, 04:32 PM |
Kogan Elona Esq. | General Counsel | Aug 20, 2019 | Option Exercise | $1.81 | 82,872 | 149,998 | 182,872 | Aug 20, 2019, 04:32 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Aug 20, 2019 | Option Exercise | $1.81 | 50,000 | 90,500 | 86,114 | Aug 20, 2019, 04:31 PM |
Brunn Carsten | President and CEO | Aug 20, 2019 | Option Exercise | $1.81 | 41,436 | 74,999 | 41,436 | Aug 20, 2019, 04:31 PM |
ZENNER PATRICK J | Director | Aug 20, 2019 | Option Exercise | $1.81 | 55,248 | 99,999 | 55,248 | Aug 20, 2019, 04:29 PM |
SPRINGER TIMOTHY A | Director | Aug 14, 2019 | Buy | $1.74 | 10,000 | 17,415 | 86,418 | Aug 16, 2019, 04:18 PM |
BARABE TIMOTHY C | Director | Aug 13, 2019 | Buy | $1.72 | 10,000 | 17,200 | 17,492 | Aug 15, 2019, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jul 23, 2019 | Option Exercise | $0.47 | 10,000 | 4,700 | 11,606 | Jul 25, 2019, 04:15 PM |
Farokhzad Omid | Director | Jan 25, 2019 | Buy | $1.50 | 83,333 | 125,000 | 83,333 | Mar 29, 2019, 04:17 PM |
SPRINGER TIMOTHY A | Director | Jan 25, 2019 | Buy | $1.50 | 66,666 | 99,999 | 76,418 | Mar 29, 2019, 04:15 PM |
SPRINGER TIMOTHY A | Director | Jan 25, 2019 | Buy | $1.50 | 4,000,000 | 6,000,000 | 4,456,597 | Mar 29, 2019, 04:15 PM |
SPRINGER TIMOTHY A | Director | Nov 10, 2017 | Buy | $9.03 | 4,752 | 42,906 | 9,752 | Mar 29, 2019, 04:15 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 07, 2019 | Option Exercise | $2.77 | 36,114 | 100,036 | 36,114 | Feb 21, 2019, 04:29 PM |
Nashat Amir | Director | Jan 25, 2019 | Buy | $1.50 | 1,166,666 | 1,749,999 | 2,676,234 | Jan 29, 2019, 04:37 PM |
Sands Earl | Chief Medical Officer | Nov 17, 2017 | Buy | $10.26 | 7,500 | 76,967 | 7,500 | Nov 21, 2017, 04:08 PM |
SPRINGER TIMOTHY A | Director | Nov 14, 2017 | Buy | $9.27 | 57,598 | 534,095 | 461,349 | Nov 16, 2017, 05:14 PM |
Abraham David | GC, CCO & Corporate Secretary | Nov 14, 2017 | Buy | $9.25 | 5,405 | 49,996 | 5,405 | Nov 14, 2017, 09:58 PM |
CAUTREELS WERNER | President and CEO | Nov 13, 2017 | Buy | $9.31 | 20,000 | 186,250 | 321,203 | Nov 14, 2017, 09:57 PM |
SPRINGER TIMOTHY A | Director | Nov 10, 2017 | Buy | $9.04 | 26,338 | 238,097 | 403,751 | Nov 13, 2017, 06:19 PM |
SPRINGER TIMOTHY A | Director | Nov 09, 2017 | Buy | $9.34 | 5,000 | 46,681 | 5,000 | Nov 13, 2017, 06:19 PM |
SPRINGER TIMOTHY A | Director | Nov 09, 2017 | Buy | $9.35 | 22,000 | 205,659 | 377,413 | Nov 13, 2017, 06:19 PM |
BARABE TIMOTHY C | Director | Nov 10, 2017 | Buy | $9.00 | 2,500 | 22,505 | 7,492 | Nov 13, 2017, 06:18 PM |
BARABE TIMOTHY C | Director | Nov 09, 2017 | Buy | $9.73 | 2,500 | 24,335 | 4,992 | Nov 13, 2017, 06:18 PM |
Nashat Amir | Director | Sep 26, 2017 | Sale | $18.91 | 70,226 | 1,328,079 | 1,550,478 | Sep 28, 2017, 05:10 PM |
Nashat Amir | Director | Sep 25, 2017 | Sale | $18.99 | 37,175 | 705,883 | 1,618,242 | Sep 26, 2017, 05:19 PM |
Nashat Amir | Director | Sep 22, 2017 | Sale | $19.26 | 42,036 | 809,781 | 1,654,114 | Sep 26, 2017, 05:19 PM |
Siewers David | CFO and Treasurer | Sep 20, 2017 | Option Exercise | $0.63 | 16,424 | 10,347 | 14,230 | Sep 22, 2017, 05:30 PM |
Siewers David | CFO and Treasurer | Sep 20, 2017 | Sale | $20.00 | 16,424 | 328,480 | 0 | Sep 22, 2017, 05:30 PM |
Nashat Amir | Director | Sep 21, 2017 | Sale | $19.86 | 104,577 | 2,076,826 | 1,694,676 | Sep 22, 2017, 04:09 PM |
Nashat Amir | Director | Sep 20, 2017 | Sale | $20.03 | 42,610 | 853,389 | 1,795,587 | Sep 22, 2017, 04:09 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jun 15, 2017 | Option Exercise | $0.47 | 10,512 | 4,941 | 12,118 | Jul 10, 2017, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jun 15, 2017 | Sale | $17.04 | 10,512 | 179,141 | 1,606 | Jul 10, 2017, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jul 03, 2017 | Option Exercise | $2.77 | 5,959 | 16,506 | 7,565 | Jul 06, 2017, 04:05 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jul 03, 2017 | Sale | $19.10 | 5,959 | 113,806 | 7,465 | Jul 06, 2017, 04:05 PM |
Siewers David | Chief Financial Officer | Jun 30, 2017 | Option Exercise | $0.63 | 7,420 | 4,675 | 7,420 | Jul 05, 2017, 12:00 AM |
Siewers David | Chief Financial Officer | Jun 30, 2017 | Sale | $20.00 | 7,420 | 148,405 | 0 | Jul 05, 2017, 12:00 AM |
Siewers David | Chief Financial Officer | Jun 29, 2017 | Option Exercise | $0.57 | 9,616 | 5,443 | 9,652 | Jun 30, 2017, 04:33 PM |
Siewers David | Chief Financial Officer | Jun 29, 2017 | Sale | $20.00 | 9,652 | 193,042 | 36 | Jun 30, 2017, 04:33 PM |
SPRINGER TIMOTHY A | Director | Jun 27, 2017 | Buy | $17.71 | 338,791 | 5,999,988 | 355,413 | Jun 28, 2017, 04:36 PM |
Keller Peter | Chief Business Officer | Jun 27, 2017 | Option Exercise | $0.63 | 4,595 | 2,895 | 5,000 | Jun 28, 2017, 04:35 PM |
Keller Peter | Chief Business Officer | Jun 27, 2017 | Sale | $19.30 | 4,595 | 88,681 | 405 | Jun 28, 2017, 04:35 PM |
Siewers David | Chief Financial Officer | Jun 26, 2017 | Sale | $20.00 | 6,886 | 137,720 | 36 | Jun 28, 2017, 04:35 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jun 15, 2017 | Option Exercise | $0.47 | 20,512 | 9,641 | 22,118 | Jun 19, 2017, 04:12 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jun 15, 2017 | Sale | $17.00 | 20,512 | 348,640 | 1,606 | Jun 19, 2017, 04:12 PM |
SPRINGER TIMOTHY A | Director | Jun 01, 2017 | Buy | $13.75 | 518 | 7,123 | 16,622 | Jun 02, 2017, 04:05 PM |
SPRINGER TIMOTHY A | Director | May 18, 2017 | Buy | $14.00 | 4,860 | 68,040 | 16,104 | May 19, 2017, 04:06 PM |
SPRINGER TIMOTHY A | Director | May 17, 2017 | Buy | $14.01 | 11,244 | 157,483 | 11,244 | May 19, 2017, 04:06 PM |
KANIA EDWIN M JR | Director | May 16, 2017 | Sale | $14.00 | 266,795 | 3,735,130 | 560,067 | May 16, 2017, 05:28 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Apr 17, 2017 | Option Exercise | $0.39 | 13,205 | 5,150 | 14,811 | Apr 18, 2017, 05:18 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Apr 17, 2017 | Sale | $13.95 | 13,205 | 184,210 | 1,606 | Apr 18, 2017, 05:18 PM |
Farokhzad Omid | Director | Mar 23, 2017 | Option Exercise | $3.92 | 60,000 | 235,108 | 188,004 | Mar 27, 2017, 04:02 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Jan 23, 2017 | Option Exercise | $0.39 | 15,000 | 5,850 | 16,606 | Jan 30, 2017, 04:54 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Jan 23, 2017 | Sale | $14.01 | 15,000 | 210,106 | 5,496 | Jan 30, 2017, 04:54 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 28, 2016 | Option Exercise | $2.77 | 10,000 | 27,700 | 10,000 | Dec 30, 2016, 06:07 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 28, 2016 | Sale | $17.55 | 10,000 | 175,500 | 0 | Dec 30, 2016, 06:07 PM |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | Dec 21, 2016 | Option Exercise | $0.47 | 12,280 | 5,772 | 14,844 | Dec 23, 2016, 02:19 PM |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | Dec 21, 2016 | Sale | $18.00 | 14,844 | 267,192 | 0 | Dec 23, 2016, 02:19 PM |
Keller Peter | Chief Business Officer | Dec 19, 2016 | Sale | $18.58 | 4,723 | 87,753 | 405 | Dec 21, 2016, 07:14 PM |
ORBIMED ADVISORS LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 08:55 PM |
RUSNANO | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 107,143 | 1,500,002 | 157,009 | Jun 29, 2016, 06:14 PM |
GORDON CARL L | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 04:49 PM |
ORBIMED ADVISORS LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 04:49 PM |
Osage University Partners II, L.P. | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 350,000 | 4,900,000 | 862,543 | Jun 29, 2016, 04:47 PM |
Nanodimension Management Ltd | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 385,000 | 5,390,000 | 1,045,957 | Jun 29, 2016, 04:46 PM |
TAS Partners, LLC | Director | Jun 27, 2016 | Buy | $14.00 | 710,000 | 9,940,000 | 1,237,028 | Jun 29, 2016, 04:45 PM |
Nashat Amir | Director | Jun 27, 2016 | Buy | $14.00 | 150,000 | 2,100,000 | 1,836,703 | Jun 29, 2016, 04:45 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 150,000 | 2,100,000 | 1,836,703 | Jun 29, 2016, 04:44 PM |
Owner | Relationship | Date | Value($) |
SPRINGER TIMOTHY A | Director | 03/08/2024 | 3,187 |
SPRINGER TIMOTHY A | Director | 03/18/2024 | 488 |
SPRINGER TIMOTHY A | Director | 02/07/2024 | 1,575 |
SPRINGER TIMOTHY A | Director | 03/15/2024 | 672 |
SPRINGER TIMOTHY A | Director | 02/06/2024 | 520 |
SPRINGER TIMOTHY A | Director | 03/14/2024 | 1,061 |
SPRINGER TIMOTHY A | Director | 01/17/2024 | 552 |
SPRINGER TIMOTHY A | Director | 03/13/2024 | 1,868 |
SPRINGER TIMOTHY A | Director | 03/12/2024 | 735 |
SPRINGER TIMOTHY A | Director | 03/11/2024 | 785 |
SPRINGER TIMOTHY A | Director | 03/26/2024 | 2,876,847 |
SPRINGER TIMOTHY A | Director | 03/18/2024 | 11,398 |
SPRINGER TIMOTHY A | Director | 03/15/2024 | 314,545 |
SPRINGER TIMOTHY A | Director | 03/14/2024 | 351,677 |
Brunn Carsten | President and CEO | 11/13/2023 | 1,073,517 |
SPRINGER TIMOTHY A | Director | 11/15/2023 | 49,999,835 |
SPRINGER TIMOTHY A | Director | 11/15/2023 | 9,999,967 |
Brunn Carsten | President and CEO | 09/25/2023 | 3,108 |
TRABER PETER G | Chief Medical Officer | 09/25/2023 | 747 |
Brunn Carsten | President and CEO | 01/05/2023 | 15,214 |
Brunn Carsten | President and CEO | 01/04/2023 | 31,287 |
Johnston Lloyd P. | Chief Operations Officer | 01/05/2023 | 3,830 |
Johnston Lloyd P. | Chief Operations Officer | 01/04/2023 | 7,247 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/05/2023 | 3,830 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/04/2023 | 7,247 |
TRABER PETER G | Chief Medical Officer | 01/05/2023 | 3,913 |
TRABER PETER G | Chief Medical Officer | 01/04/2023 | 9,273 |
Brunn Carsten | President and CEO | 12/05/2022 | 6,014 |
Brunn Carsten | President and CEO | 09/28/2022 | 4,470 |
Brunn Carsten | President and CEO | 09/02/2022 | 8,810 |
COX CARRIE SMITH | Director | 06/13/2022 | 149,799 |
BARABE TIMOTHY C | Director | 05/09/2022 | 38,720 |
BARABE TIMOTHY C | Director | 01/14/2022 | 21,000 |
TRABER PETER G | Chief Medical Officer | 01/05/2022 | 9,955 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/05/2022 | 10,541 |
Johnston Lloyd P. | Chief Operations Officer | 01/05/2022 | 10,541 |
Brunn Carsten | President and CEO | 01/05/2022 | 41,959 |
SPRINGER TIMOTHY A | Director | 12/15/2021 | 631,099 |
TRABER PETER G | Chief Medical Officer | 12/10/2021 | 12,196 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/10/2021 | 13,053 |
Johnston Lloyd P. | Chief Operations Officer | 12/10/2021 | 13,053 |
Brunn Carsten | President and CEO | 12/10/2021 | 51,363 |
SPRINGER TIMOTHY A | Director | 12/13/2021 | 43,491 |
SPRINGER TIMOTHY A | Director | 12/10/2021 | 175,439 |
SPRINGER TIMOTHY A | Director | 12/09/2021 | 11,468,880 |
Tan Kevin | Chief Financial Officer | 12/02/2021 | 15,127 |
DeSilva Nishan M | Director | 12/02/2021 | 20,723 |
COX CARRIE SMITH | Director | 12/03/2021 | 50,664 |
Brunn Carsten | President and CEO | 12/02/2021 | 14,065 |
TRABER PETER G | Chief Medical Officer | 10/13/2021 | 15,962 |
Kishimoto Takashi Kei | Chief Scientific Officer | 10/13/2021 | 17,086 |
Johnston Lloyd P. | Chief Operations Officer | 10/13/2021 | 17,086 |
Brunn Carsten | President and CEO | 10/13/2021 | 67,224 |
Brunn Carsten | President and CEO | 09/02/2021 | 20,399 |
BARABE TIMOTHY C | Director | 08/18/2021 | 36,000 |
BARABE TIMOTHY C | Director | 03/26/2021 | 41,000 |
TRABER PETER G | Chief Medical Officer | 03/18/2021 | 45,000 |
TRABER PETER G | Chief Medical Officer | 03/17/2021 | 45,295 |
Johnston Lloyd P. | COO and SVP, R&D | 03/17/2021 | 67,312 |
Brunn Carsten | President and CEO | 03/02/2021 | 23,257 |
Johnston Lloyd P. | COO and SVP, R&D | 02/11/2021 | 28,269 |
TRABER PETER G | Chief Medical Officer | 12/14/2020 | 129,424 |
Brunn Carsten | President and CEO | 12/02/2020 | 11,134 |
Kishimoto Takashi Kei | Chief Scientific Officer | 10/23/2020 | 83,100 |
SPRINGER TIMOTHY A | Director | 10/23/2020 | 2,699,737 |
SPRINGER TIMOTHY A | Director | 10/22/2020 | 4,656,699 |
SPRINGER TIMOTHY A | Director | 10/21/2020 | 2,199,472 |
SPRINGER TIMOTHY A | Director | 10/20/2020 | 2,013,193 |
SPRINGER TIMOTHY A | Director | 10/19/2020 | 1,795,002 |
SPRINGER TIMOTHY A | Director | 10/16/2020 | 528,034 |
SPRINGER TIMOTHY A | Director | 10/09/2020 | 552,465 |
SPRINGER TIMOTHY A | Director | 10/08/2020 | 1,000,836 |
SPRINGER TIMOTHY A | Director | 10/07/2020 | 1,078,577 |
SPRINGER TIMOTHY A | Director | 10/06/2020 | 3,365,800 |
BARABE TIMOTHY C | Director | 10/06/2020 | 83,985 |
Brunn Carsten | President and CEO | 09/02/2020 | 8,035 |
BARABE TIMOTHY C | Director | 06/24/2020 | 47,946 |
Brunn Carsten | President and CEO | 06/02/2020 | 12,557 |
BARABE TIMOTHY C | Director | 03/17/2020 | 10,000 |
Brunn Carsten | President and CEO | 03/03/2020 | 13,011 |
Johnston Lloyd P. | COO and SVP, R&D | 01/16/2020 | 2,410 |
BARABE TIMOTHY C | Director | 12/23/2019 | 95,894 |
SPRINGER TIMOTHY A | Director | 12/23/2019 | 5,753,695 |
COX CARRIE SMITH | Director | 12/23/2019 | 95,894 |
Myers Scott Dunseth | Director | 12/23/2019 | 57,537 |
Brunn Carsten | President and CEO | 12/02/2019 | 21,809 |
SPRINGER TIMOTHY A | Director | 08/20/2019 | 1,991,000 |
SPRINGER TIMOTHY A | Director | 08/20/2019 | 2,896,000 |
Smolinski Stephen | Chief Commercial Officer | 08/20/2019 | 25,000 |
Myers Scott Dunseth | Director | 08/20/2019 | 74,999 |
Kogan Elona Esq. | General Counsel | 08/20/2019 | 149,998 |
Kishimoto Takashi Kei | Chief Scientific Officer | 08/20/2019 | 90,500 |
Brunn Carsten | President and CEO | 08/20/2019 | 74,999 |
ZENNER PATRICK J | Director | 08/20/2019 | 99,999 |
SPRINGER TIMOTHY A | Director | 08/14/2019 | 17,415 |
BARABE TIMOTHY C | Director | 08/13/2019 | 17,200 |
Johnston Lloyd P. | COO and SVP, R&D | 07/23/2019 | 4,700 |
Farokhzad Omid | Director | 01/25/2019 | 125,000 |
SPRINGER TIMOTHY A | Director | 01/25/2019 | 99,999 |
SPRINGER TIMOTHY A | Director | 01/25/2019 | 6,000,000 |
SPRINGER TIMOTHY A | Director | 11/10/2017 | 42,906 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/07/2019 | 100,036 |
Nashat Amir | Director | 01/25/2019 | 1,749,999 |
Sands Earl | Chief Medical Officer | 11/17/2017 | 76,967 |
SPRINGER TIMOTHY A | Director | 11/14/2017 | 534,095 |
Abraham David | GC, CCO & Corporate Secretary | 11/14/2017 | 49,996 |
CAUTREELS WERNER | President and CEO | 11/13/2017 | 186,250 |
SPRINGER TIMOTHY A | Director | 11/10/2017 | 238,097 |
SPRINGER TIMOTHY A | Director | 11/09/2017 | 46,681 |
SPRINGER TIMOTHY A | Director | 11/09/2017 | 205,659 |
BARABE TIMOTHY C | Director | 11/10/2017 | 22,505 |
BARABE TIMOTHY C | Director | 11/09/2017 | 24,335 |
Nashat Amir | Director | 09/26/2017 | 1,328,079 |
Nashat Amir | Director | 09/25/2017 | 705,883 |
Nashat Amir | Director | 09/22/2017 | 809,781 |
Siewers David | CFO and Treasurer | 09/20/2017 | 10,347 |
Siewers David | CFO and Treasurer | 09/20/2017 | 328,480 |
Nashat Amir | Director | 09/21/2017 | 2,076,826 |
Nashat Amir | Director | 09/20/2017 | 853,389 |
Johnston Lloyd P. | COO and SVP, R&D | 06/15/2017 | 4,941 |
Johnston Lloyd P. | COO and SVP, R&D | 06/15/2017 | 179,141 |
Johnston Lloyd P. | COO and SVP, R*D | 07/03/2017 | 16,506 |
Johnston Lloyd P. | COO and SVP, R*D | 07/03/2017 | 113,806 |
Siewers David | Chief Financial Officer | 06/30/2017 | 4,675 |
Siewers David | Chief Financial Officer | 06/30/2017 | 148,405 |
Siewers David | Chief Financial Officer | 06/29/2017 | 5,443 |
Siewers David | Chief Financial Officer | 06/29/2017 | 193,042 |
SPRINGER TIMOTHY A | Director | 06/27/2017 | 5,999,988 |
Keller Peter | Chief Business Officer | 06/27/2017 | 2,895 |
Keller Peter | Chief Business Officer | 06/27/2017 | 88,681 |
Siewers David | Chief Financial Officer | 06/26/2017 | 137,720 |
Johnston Lloyd P. | COO and SVP, R*D | 06/15/2017 | 9,641 |
Johnston Lloyd P. | COO and SVP, R*D | 06/15/2017 | 348,640 |
SPRINGER TIMOTHY A | Director | 06/01/2017 | 7,123 |
SPRINGER TIMOTHY A | Director | 05/18/2017 | 68,040 |
SPRINGER TIMOTHY A | Director | 05/17/2017 | 157,483 |
KANIA EDWIN M JR | Director | 05/16/2017 | 3,735,130 |
Johnston Lloyd P. | COO AND SVP, R&D | 04/17/2017 | 5,150 |
Johnston Lloyd P. | COO AND SVP, R&D | 04/17/2017 | 184,210 |
Farokhzad Omid | Director | 03/23/2017 | 235,108 |
Johnston Lloyd P. | COO AND SVP, R&D | 01/23/2017 | 5,850 |
Johnston Lloyd P. | COO AND SVP, R&D | 01/23/2017 | 210,106 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/28/2016 | 27,700 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/28/2016 | 175,500 |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | 12/21/2016 | 5,772 |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | 12/21/2016 | 267,192 |
Keller Peter | Chief Business Officer | 12/19/2016 | 87,753 |
ORBIMED ADVISORS LLC | Director | 06/27/2016 | 7,700,000 |
RUSNANO | 10% Owner | 06/27/2016 | 1,500,002 |
GORDON CARL L | Director | 06/27/2016 | 7,700,000 |
ORBIMED ADVISORS LLC | Director | 06/27/2016 | 7,700,000 |
Osage University Partners II, L.P. | 10% Owner | 06/27/2016 | 4,900,000 |
Nanodimension Management Ltd | 10% Owner | 06/27/2016 | 5,390,000 |
TAS Partners, LLC | Director | 06/27/2016 | 9,940,000 |
Nashat Amir | Director | 06/27/2016 | 2,100,000 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 06/27/2016 | 2,100,000 |
Period of Report: 06/30/2023
10-K/10-Q Filings: View